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Abstract
Numerous researches show that data on an ethnic origin can give additional information 
for the personified approach in treatment of different diseases. The aim of this study was to 
evaluate the level of some lipid peroxidation components and antioxidant defense system 
in Mongoloid and Caucasian patients with Type 1 diabetes mellitus. Conjugated dienes, 
ketodienes and conjugated trienes, thiobarbituric acid reactants, total antioxidant activ-
ity, α-tocopherol, retinol, superoxide dismutase activity, reduced and oxidized glutathione, 
and oxidative stress coefficient levels were evaluated in 65 patients with type 1 diabetes (38 
Mongoloids and 27 Caucasians) and in 82 healthy people (42 Mongoloids and 40 Caucasians). 
Spectrophotometric and fluorometric methods were used. The intensity of LPO in Mongoloid 
patients was lower than in Caucasians: the level of primary and intermediate products was 
by lower 1.53 and 1.83 times, while total antioxidant activity was elevated by 1.44 times, and 
decreased α-tocopherol level by 1.32 times, which was also supported by oxidative stress 
coefficient (1.35 in Mongoloids and 2.32 in Caucasians). Activity of the POL-AOD system in 
Mongoloids is low, which is probably due to the increase of antioxidant defense system work. 
These results are consistent with clinical characteristics of type 1 diabetes mellitus with infre-
quent development of complications in Mongoloids living in Eastern Siberia.
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1. Introduction
Type 1 diabetes mellitus (T1DM) is common in the world and is considered as one of the 
severe human diseases. This disease is the cause of heart disease, blindness, stroke, kidney 
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failure, foot ulcers, and so on. A number of studies have shown that complications rate of 
T1DM depends on different factors including geographic residence and human ethnicity 
[1–4]. The dominance of T1DM is there in the countries of Scandinavia—Finland and Sweden 
(63 cases per 100,000 population) [5], while the lowest prevalence is observed in the East and 
South-East Asia where representatives of the Mongoloid race live [6]. In Russian Federation, 
there are more than 250,000 patients with T1DM [7]. Some studies revealed that low morbid-
ity of T1DM among the aboriginal people in Arctic and Siberian regions resulted from the 
presence of the protective allele’s genes for this disorder [6]. The prevalence of this form of 
diabetes among indigenous people in the Buryatia Republic is 24.18 per 100,000, which is 
below the average level in Russia (224.5 per 100,000) [8, 9].
Oxidative stress is an imbalance between increase reactive oxygen species and an antioxidant 
ability to detoxify the reactive components. Oxidative stress is thought to be involved in the 
development of different diseases [10–12].
Many experimental [13] and clinical studies [14] suggest that free-radical processes are acti-
vated during different stages and in different types of diabetes mellitus, even in its subclini-
cal forms [15, 16]. In patients with diabetes mellitus, oxidative stress (OS) caused by elevated 
production of reactive species of oxygen and decrease of antioxidant defense system (AOD) 
level, leads to activation of lipid peroxidation (LPO) and oxidative lipoprotein modification 
with increasing atherogenicity [17]. Hyperglycemia can induce damage of β-cells functions 
with development of OS and decrease of thioredoxine level [18]. Marra et al. suggest that 
T1DM patients with a short duration of disease and good metabolic control show an early 
imbalance in their antioxidant capacity and augmented levels of lipid hydroperoxides and 
conjugated dienes (CDs) [19]. Diabetic women show, independently from other factors, a 
decreased antioxidant capacity and an increased rate of lipoperoxidation compared with 
diabetic men [19].
At the same time, the link between certain metabolic characteristics in patients with T1DM 
and their race remains poorly studied. The aim of this study was to evaluate the level 
of some LPO components and AOD system in Mongoloid and Caucasian patients with 
T1DM.
2. An evaluation of the level of some lipid peroxidation components 
and antioxidant defense system in mongoloid and Caucasian 
patients with type 1 diabetes mellitus
Biochemical parameters in 147 persons (healthy and with T1DM) both Mongoloids (ethnic 
group is Buryats) and Caucasians (ethnic group is Russians) living in the modern city Ulan-
Ude (East-Siberia) were assessed. The diagnosis of T1DM was confirmed in all patients based 
on clinical and laboratory investigations, severe comorbidities and severe diabetic complica-
tions were excluded. Main group’s characteristics are presented in Table 1. There were no 
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statistically significant differences in sex, age, duration of disease, Hb A1C, body mass index (BMI), arterial pressure in T1DM groups. There were no statistically significant differences in 
diets and physical activity between the patients of both ethnic groups with T1DM.
Blood samples were taken after 12 h of fasting during night, then were centrifuged for 5 min 
at 4°C, and erythrocytes were washed three times with NaCI 0.9% (wt/vol). Aliquots of EDTA 
plasma and washed erythrocytes were used immediately or kept frozen at −40°С but not 
more than 1 month. Blood plasma and hemolysate were used as the materials for analysis. 
The blood was taken from the cubital vein in accordance with accepted requirements. The 
intensity of LPO was evaluated by the level of diene conjugates (DC), ketodienes (KD), and 
conjugated trienes (CT). The concentration of DCs detected on absorbance of plasma hep-
tanes extracts at 232 nm (μmol/liter), KD and CT at 278 nm (arb. units) [20]. Thiobarbituric 
acid reactants (TBARs) levels were identified by fluorometry methods and were considered 
in μmol/liter [21]. An evaluation of АОD activity was carried out on total radical-trapping 
antioxidant parameter (TRAР), which was measured by specific methods on 2,2′-azinobis-
(3-ethylbensothazoline-6-sulphonate) radical action formation (absorbance at 734 nm) in con-





Also contents of other components of AOD system were determined: α-tocopherol and retinol 
[23], superoxide dismutase (SOD) [24], and reduced and oxidized glutathione (GSH and the 
GSSG) [25]. Measurements were carried out on the Shimadzu RF-1501 and Shimadzu RF-1650 
spectrofluorometer. For more informative description of the LPO–AOD, coefficient of oxida-
tive stress (COS) was calculated as the ratio of LPO–AOD system values in T1DM patient 




T1DM Control group T1DM Control group
n 38 42 27 40
Sex (M / F) 15/23 22/20 15/12 20/20
Age (years) 34.4 ± 11.7 31.4 ± 8.0 32.7 ± 11.9 27.8 ± 7.7
Duration of disease (years) 12.1 ± 3.5 – 12.9 ± 4.0 –
Hb A1C (%) 9.29 ± 3.06 – 8.74 ± 2.24 –
Body mass index (kg/m2) 23.7 ± 2.1 20.3 ± 1.3 24.6 ± 3.1 21.4 ± 3.4
Total cholesterol (mmol/l) 4.65 ± 1.2 4.28 ± 1.29 5.66 ± 1.22 4.24 ± 1.25
Triglycerides level (mmol/l) 1.01 ± 0.58 0.67 ± 0.21 1.53 ± 0.66 0.54 ± 0.19
Systolic pressure (mm Hg) 115 ± 11 116 ± 12 117 ± 10 113 ± 11
Diastolic pressure (mm Hg) 73 ± 12 71 ± 12 74 ± 9 76 ± 12
Table 1. General characteristics of patients with T1DM and control subjects.
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all patients and control groups signed informed consent according to the World Medical 
Association Declaration of Helsinki (1964, 2000). For statistic analysis of the data, Statistica 
6.1 software (StatSoft Inc.) was used. To determine normal distribution of the quantitative 
data, graphic visual method and Kolmogorov-Smirnov Test with Lilliefors and Shapiro-Wilk 
corrections were used. The variances equality was verified by Fisher’s Test. Descriptive statis-
tics was applied for quantitative data description: mean ± error of the mean. The differences 
between parameters of groups by parametric Student’s Test for independent samples and 
non-parametric Mann–Whitney Test were analyzed. The critical significance level was con-
sidered 5% (p < 0.05).
3. Results
The oxidative stress is considered an imbalance in the redox-state with isolated or combined 
variations in the pro- or antioxidant components concentration. Our study has shown higher 
concentration of DC (by 1.35 times; p < 0.01) in Mongoloid patients as well as higher levels of 
DC (by 2.4 times; p < 0.001) and KD and CT (by 2.71 times; p < 0.05) in Caucasian patients in 
comparison to the corresponding control groups (Table 2).
No statistically significant differences between investigated groups in the TBA-reactive prod-
ucts level of lipid peroxidation processes were identified. In conditions of increased genera-
tion of LPO products are observed changes permeability of cell membranes for a lot of ions, 
nonelectrolytes, and macromolecules [27]. This processes in loss of barrier function of cell 
membranes that is the pathogenesis of different diseases, including development of vascu-
lar disorders in T1DM due to lipid peroxidation activation during prolonged hyperglycemia 
[9, 28]. The observed increase in LPO activity cannot provide sufficient information about 
the redox-status in patients with T1DM, because it indicates one aspect of the study, LPO 
excluding of AOD activity. The study of the AOD integral parameter level, TRAP in patients 
with T1DM, an increase (by 1.54 times; p < 0.001) in this indicator in Mongoloid patients in 
comparison with the control group was shown (Table 3).
In Caucasian patients with T1DM, statistically significant differences from the control group 
included reduced GSH values (by 1.16 times; p < 0.05) and increased GSSG level (1.26-times, 
Parameters Mongoloids Caucasians
Control group T1DM Control group T1DM
Diene conjugates, μmol/liter 0.57 ± 0.03 0.77 ± 0.04* 0.51 ± 0.07 1.2 ± 0.11*,+
Ketodienes and conjugated 
trienes, arb. units
0.31 ± 0.05 0.35 ± 0.04 0.24 ± 0.06 0.65 ± 0.13*,+
TBA-reactive products, μmol/liter 1.57 ± 0.10 1.81 ± 0.11 1.93 ± 0.10 2.05 ± 0.12
Here and in Table 3: p < 0.05 in comparison with *corresponding control, +Caucasian T1DM patients.
Table 2. Level of LPO products in DM1 mongoloid and Caucasian patients (M ± m).
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p < 0.001) (Table 2). Also in this group in comparison with control, statistically significant 
differences in activity of SOD, α-tocopherol, and retinol levels were not noted. Initiation of pro-
cesses of lipid peroxidation at primary and intermediate stages in the absence of natural AОD 
activity enhancement can lead to function impairment of different components of hemostasis 
and increased aggregation of blood cell, which will increase blооd viscosity, induce thicken-
ing of the vascular wall basal membrane, slower blооd flow in small and medium vessels, 
deterioration of micrоcirculation [24]. The given changes in parameters of lipid peroxidation 
can attest about the presence of risk factors for microangiopathy development in Caucasian 
patients with T1DM. Comparison of LPO values in Caucasian and Mongoloid patients showed 
decreased DC (by 1.56 times; p < 0.001), KD and CT (by 1.86 times; p < 0.05) values, increased 
TRAP (by 1.44 times; p < 0.001), and decreased α-tocopherol levels (1.22-times, p < 0.01) in 
Mongoloid patients with T1DM in compare with the same values in Caucasian patients with 
T1DM (Tables 1 and 2). Coefficient of oxidative stress (COS) in Mongoloid patients was 1.35, 
in Caucasian patients was 2.32 (p < 0.05). It is believed that CОS value>1 indicates activation 
of oxidative stress. The higher is CОS, the more insensitive are processes lipid peroxidation 
processes and less effective is the antioxidant defense system in the examined patients with 
different diseases. So, our results indicate increased LPO processes in grоups of patients with 
diabetes mellitus and intensity of LPO processes depends on ethnicity [29]. Noted changes in 
LPO-AOD system in Mongoloid patients with T1DM were less insensitive than in Caucasian 
patients, that allows to make a recommendation on highly individualized approaches to the 
cоmplex therapy.
4. Conclusions
We suppose that ethnic factor plays one of the most important roles in the course of various 
diseases, including T1DM. It is quite possible that the low incidence in T1DM in Mongoloids 
is based on less LPO-AOD metabolic imbalance. Further studies of ethnically associated met-
abolic features can give more opportunities for developing specific approaches for diagnos-
tics, prophylactic and treatment of T1DM in patients of different ethnic groups.
Parameters Mongoloids Caucasians
Control group T1DM Control group T1DM
TRAP, arb. Units 14.35 ± 0.72 22.17 ± 1.08* 17.68 ± 1.36 15.42 ± 0.96+
α-tocopherol, μmol/liter 6.85 ± 0.38 6.23 ± 0.32 6.72 ± 0.3 8.21 ± 0.78*,+
retinol, μmol/liter 2.7 ± 0.18 2.29 ± 0.15 2.38 ± 0.13 2.33 ± 0.17
SOD, arb. Units 1.41 ± 0.04 1.26 ± 0.03 1.43 ± 0.44 1.57 ± 0.24
GSH, mmol/liter 2.79 ± 0.16 2.79 ± 0.11 2.90 ± 0.14 2.51 ± 0.13*
GSSG, mmol/liter 2.03 ± 0.15 2.15 ± 0.09 1.72 ± 0.09 2.16 ± 0.10*
Table 3. AOD values in T1DM in mongoloid and Caucasian patients (M ± m).
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